Advisors Asset Management’s Emergent Biosolutions EBS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-1,493
| Closed | -$5.08K | – | 1411 |
|
2023
Q3 | $5.08K | Sell |
1,493
-325
| -18% | -$1.11K | ﹤0.01% | 1397 |
|
2023
Q2 | $13.4K | Sell |
1,818
-1,742
| -49% | -$12.8K | ﹤0.01% | 1392 |
|
2023
Q1 | $36.9K | Sell |
3,560
-156
| -4% | -$1.62K | ﹤0.01% | 1336 |
|
2022
Q4 | $43.9K | Sell |
3,716
-2,810
| -43% | -$33.2K | ﹤0.01% | 1352 |
|
2022
Q3 | $137K | Sell |
6,526
-199
| -3% | -$4.18K | ﹤0.01% | 1210 |
|
2022
Q2 | $209K | Sell |
6,725
-2,479
| -27% | -$77K | ﹤0.01% | 1155 |
|
2022
Q1 | $378K | Sell |
9,204
-430
| -4% | -$17.7K | 0.01% | 1082 |
|
2021
Q4 | $419K | Buy |
9,634
+975
| +11% | +$42.4K | 0.01% | 1055 |
|
2021
Q3 | $434K | Buy |
8,659
+681
| +9% | +$34.1K | 0.01% | 1057 |
|
2021
Q2 | $503K | Buy |
7,978
+1,072
| +16% | +$67.6K | 0.01% | 1000 |
|
2021
Q1 | $642K | Buy |
6,906
+1,498
| +28% | +$139K | 0.01% | 956 |
|
2020
Q4 | $485K | Buy |
5,408
+2,687
| +99% | +$241K | 0.01% | 977 |
|
2020
Q3 | $281K | Buy |
2,721
+1,350
| +98% | +$139K | 0.01% | 1083 |
|
2020
Q2 | $108K | Buy |
1,371
+1,309
| +2,111% | +$103K | ﹤0.01% | 1287 |
|
2020
Q1 | $4K | Sell |
62
-208
| -77% | -$13.4K | ﹤0.01% | 1449 |
|
2019
Q4 | $15K | Sell |
270
-10
| -4% | -$556 | ﹤0.01% | 1479 |
|
2019
Q3 | $15K | Sell |
280
-2
| -0.7% | -$107 | ﹤0.01% | 1496 |
|
2019
Q2 | $14K | Buy |
282
+15
| +6% | +$745 | ﹤0.01% | 1481 |
|
2019
Q1 | $13K | Buy |
267
+174
| +187% | +$8.47K | ﹤0.01% | 1736 |
|
2018
Q4 | $6K | Buy |
+93
| New | +$6K | ﹤0.01% | 1540 |
|
2017
Q1 | – | Sell |
-7,464
| Closed | -$245K | – | 1611 |
|
2016
Q4 | $245K | Sell |
7,464
-108
| -1% | -$3.55K | ﹤0.01% | 1336 |
|
2016
Q3 | $239K | Sell |
7,572
-9
| -0.1% | -$284 | ﹤0.01% | 1315 |
|
2016
Q2 | $213K | Sell |
7,581
-186
| -2% | -$5.23K | ﹤0.01% | 1335 |
|
2016
Q1 | $282K | Buy |
7,767
+1,738
| +29% | +$63.1K | ﹤0.01% | 1238 |
|
2015
Q4 | $241K | Buy |
+6,029
| New | +$241K | ﹤0.01% | 1344 |
|